A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer
暂无分享,去创建一个
A. Giuliani | M. Baiocchi | A. Pagliuca | M. Signore | G. Minchiotti | O. Tcheremenskaia | V. D’Andrea | R. De Maria | F. Francescangeli | A. Zeuner | O. Guardiola | Federico Salaris | T. Haas | A. Ciardi | A. Boe | J. Medema | L. Colace | M. L. De Angelis | Filippo La Torre | P. Contavalli | S. Careccia | M. D. De Angelis | Alessandra Boe | Federica Francescangeli
[1] F. Francescangeli,et al. Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance , 2019, Front. Oncol..
[2] Yibin Kang,et al. Context-dependent EMT programs in cancer metastasis , 2019, The Journal of experimental medicine.
[3] D. Kerr,et al. An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance , 2019, Oncogenesis.
[4] T. Brabletz,et al. Non-redundant functions of EMT transcription factors , 2019, Nature Cell Biology.
[5] R. Sreekumar,et al. Assessment of Nuclear ZEB2 as a Biomarker for Colorectal Cancer Outcome and TNM Risk Stratification , 2018, JAMA network open.
[6] J. Tabernero,et al. TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence , 2018, The Journal of clinical investigation.
[7] S. Buczacki,et al. Itraconazole perturbs colorectal cancer dormancy through SUFU-mediated WNT inhibition , 2018, Molecular & cellular oncology.
[8] S. Ramaswamy,et al. AKT1low quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer , 2017, Breast Cancer Research.
[9] S. Ramaswamy,et al. Persistence of AKT1 low quiescent cancer cells after neoadjuvant chemotherapy in triple negative breast cancer patients. , 2017 .
[10] R. Weinberg,et al. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications , 2017, Nature Reviews Clinical Oncology.
[11] W. Hahn,et al. The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia. , 2017, Blood.
[12] H. Fröhlich,et al. The EMT transcription factor Zeb2 controls adult murine hematopoietic differentiation by regulating cytokine signaling. , 2017, Blood.
[13] W. Hiddemann,et al. Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia , 2016, Cancer cell.
[14] D. Lambrechts,et al. Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching , 2016, British Journal of Cancer.
[15] G. Stassi,et al. A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype , 2016, Oncogene.
[16] L. Ricci-Vitiani,et al. Cancer Stem Cell‐Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance , 2016, Stem cells translational medicine.
[17] Chih-Yang Wang,et al. Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells , 2015, Nature.
[18] M. Zheng,et al. The metastasis suppressor, NDRG1, inhibits “stemness” of colorectal cancer via down-regulation of nuclear β-catenin and CD44 , 2015, Oncotarget.
[19] Jeffrey S. Morris,et al. The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.
[20] S. Anand,et al. Kinase-independent role for CRAF-driving tumour radioresistance via CHK2 , 2015, Nature Communications.
[21] Camille Stephan-Otto Attolini,et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer , 2015, Nature Genetics.
[22] M. Todaro,et al. Colorectal cancer stem cells: from the crypt to the clinic. , 2014, Cell stem cell.
[23] V. Espina,et al. Reverse Phase Protein Arrays: Mapping the Path Towards Personalized Medicine , 2014, Molecular Diagnosis & Therapy.
[24] P. Bragado,et al. Mechanisms of disseminated cancer cell dormancy: an awakening field , 2014, Nature Reviews Cancer.
[25] M. Biffoni,et al. Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer , 2014, Cell Death and Differentiation.
[26] Steven J. M. Jones,et al. Quiescent sox2(+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma. , 2014, Cancer cell.
[27] A. Krešo,et al. Evolution of the cancer stem cell model. , 2014, Cell stem cell.
[28] V. Gogvadze,et al. Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments , 2014, Nature Communications.
[29] A. Krešo,et al. Self-renewal as a therapeutic target in human colorectal cancer , 2013, Nature Medicine.
[30] P. Bragado,et al. TGFβ2 dictates disseminated tumour cell fate in target organs through TGFβ-RIII and p38α/β signalling , 2013, Nature Cell Biology.
[31] S. Thorgeirsson,et al. NANOG modulates stemness in human colorectal cancer , 2013, Oncogene.
[32] J. Taunton,et al. p90 RSK2 Mediates Antianoikis Signals by both Transcription-Dependent and -Independent Mechanisms , 2013, Molecular and Cellular Biology.
[33] Florian Markowetz,et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions , 2013, Nature Medicine.
[34] H. Rui,et al. Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer. , 2013, Cancer research.
[35] John M. Ashton,et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. , 2013, Cell stem cell.
[36] Andrew M. K. Brown,et al. Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer , 2013, Science.
[37] M. Biffoni,et al. Proliferation State and Polo‐Like Kinase1 Dependence of Tumorigenic Colon Cancer Cells , 2012, Stem cells.
[38] Tzong-Shiue Yu,et al. A restricted cell population propagates glioblastoma growth following chemotherapy , 2012, Nature.
[39] M. Koch,et al. Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. , 2011, Cell stem cell.
[40] M. Esteller,et al. Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis , 2011, Oncogene.
[41] Giovanni Calcagnini,et al. A Systems Biology Strategy on Differential Gene Expression Data Discloses Some Biological Features of Atrial Fibrillation , 2010, PloS one.
[42] Simone Brabletz,et al. The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer? , 2010, EMBO reports.
[43] Alexander Roesch,et al. A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth , 2010, Cell.
[44] N. Cho,et al. CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells , 2010, Oncogene.
[45] Louis Vermeulen,et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.
[46] Satoshi Tanaka,et al. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML , 2010, Nature Biotechnology.
[47] S. Krauss,et al. Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma , 2009, Clinical & Experimental Metastasis.
[48] M. Todaro,et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity , 2008, Proceedings of the National Academy of Sciences.
[49] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[50] G. Goodall,et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.
[51] W. Min,et al. Chemoresistance of endothelial cells induced by basic fibroblast growth factor depends on Raf-1-mediated inhibition of the proapoptotic kinase, ASK1. , 2007, Cancer research.
[52] Barbara J. Wold,et al. Mining gene expression data by interpreting principal components , 2006, BMC Bioinformatics.
[53] S. Elledge,et al. Multiple Tumor Suppressor Pathways Negatively Regulate Telomerase , 2003, Cell.
[54] G. Berx,et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. , 2001, Molecular cell.
[55] Xuan Sun,et al. Akt Phosphorylates and Negatively Regulates Apoptosis Signal-Regulating Kinase 1 , 2001, Molecular and Cellular Biology.
[56] L. Liotta,et al. Utilization of Proteomic Technologies for Precision Oncology Applications. , 2019, Cancer treatment and research.